Evaluation of the Synergism Mechanism of Tamoxifen and Docetaxel by Nanoparticles
Author:
Affiliation:
1. College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China
2. College of Pharmacy, Liaoning University, Shenyang 110036, China
Abstract
Funder
Zhejiang Chinese Medical University
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Pharmacology,Molecular Medicine
Reference18 articles.
1. Peter M.; Ellis E.T.V.; Yee C.; Ung, Immune checkpoint inhibitors for patients with advanced nonesmall-cell lung cancer: A systematic review. Clin Lung Cancer 2017,18(5),444-459
2. Visconti R.; Grieco D.; Fighting tubulin-targeting anticancer drug toxicity and resistance. Endocr Relat Cancer 2017,24(9),T107-T117
3. Azzoli C.G.; Baker S.; Temin S.; Pao W.; Aliff T.; Brahmer J.; Johnson D.H.; Laskin J.L.; Masters G.; Milton D.; Nordquist L.; Pfister D.G.; Piantadosi S.; Schiller J.H.; Smith R.; Smith T.J.; Strawn J.R.; Trent D.; Giaccone G.; American Society of Clinical Oncology. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 2009,27(36),6251-6266
4. Choudhury B.G.; Pandeya M.; Kumbharc S.A.; Tekaded R.K.; Iyere A.K.; Kesharwani P.; Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy. Int J Pharm 2017,2017(529),506-522
5. (a) Jain, A.K.; Sanyog Jain, K.T. Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: Implications on oral bioavailability, antitumor efficacy and drug induced toxicit. Mol. Pharm., 2013, 2013(10), 3459-3474. (b Shien, T.; Iwata, H.; Aogi, K.; Fukutomi, T.; Inoue, K.; Kinoshita, T.; Takahashi, M.; Matsui, A.; Shibata, T.; Fukuda, H. Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: Results of a Japan Clinical Oncology Group Study (JCOG9401). Int J Clin Oncol 2014,19(6),982-988
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Study of the radiosensitization of docetaxel in human esophageal squamous carcinoma ECA109 cell line;PAK J PHARM SCI;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3